Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

GlaxoSmithKline Buys Back 1.3 Million Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/04/2012 | 06:28pm CET

GlaxoSmithKline PLC (>> GlaxoSmithKline plc) said Friday it has purchased 1,300,000 ordinary shares to be held in treasury.

MAIN FACTS:

-Highest price paid: 1455 pence per share.

-Lowest price paid: 1425 pence per share.

-Shares at 1610 GMT down 1%, at 1427 pence, valuing the company at GBP72 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; mark.shapland@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc, GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
02/24 JUSTIFICATION AND APPROVAL - 65-- RE : 00173-0681-22
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
02/23 GLAXOSMITHKLINE : Positive results for Relvar Ellipta Lung Study
02/23 GLAXOSMITHKLINE : Glaxo Gets Positive Headline Results On Relvar-Ellipta Asthma ..
02/23 GLAXOSMITHKLINE : Positive Results for Relvar® Ellipta® Lung Function Study in P..
02/23 GLAXOSMITHKLINE : Positive results for Relvar® Ellipta® lung function study in p..
02/23DJPURETECH HEALTH : Appoints Atul Pande as Chief Medical Officer
02/23 GLAXOSMITHKLINE PLC : ex-dividend day for final dividend
02/21 KORN FERRY : Futurestep Partners with GlaxoSmithKline to Support Talent Acquisit..
02/17 European shares retreat after week of gains; Allianz rallies after update
More news
Sector news : Pharmaceuticals - NEC
09:38pDJJOHNSON & JOHNSON : Prescription Unit List Prices Rose 8.5% Last Year
06:13p FTSE ends higher on some positive earnings, insurers slip
08:06aDJSANOFI : Lonza to Invest CHF290 Million in New Plant in Switzerland
02/24DJSHIRE : Files 8K - Other Events
02/24DJASTRAZENECA : Hyperkalaemia Drug Clears Scientific Hurdle for European Approval
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
11:03a RESVERLOGIX : The Science Is Getting 'BETter' For RVX208
02/26 BIOTECH FORUM DAILY DIGEST : Can Aerie Pharmaceuticals Continue To Rally? Spotli..
02/24 I'M SICK AND TIRED OF GILEAD SCIENCE : Part 2
02/24 GILEAD : No HCV? No Problem
02/23 GlaxoSmithKline's Valuation Is Compelling
Advertisement
Financials ( GBP)
Sales 2017 29 948 M
EBIT 2017 8 405 M
Net income 2017 4 175 M
Debt 2017 13 565 M
Yield 2017 4,88%
P/E ratio 2017 20,29
P/E ratio 2018 17,01
EV / Sales 2017 3,14x
EV / Sales 2018 3,01x
Capitalization 80 506 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 17,7  GBP
Spread / Average Target 7,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Birgitte Volck Head-Research & Development
Moncef Slaoui Executive Director & Chairman-Global Vaccines
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC4.96%100 321
JOHNSON & JOHNSON6.53%333 891
ROCHE HOLDING LTD.5.42%210 192
PFIZER INC.5.48%207 902
NOVARTIS AG4.72%202 648
MERCK & CO., INC.12.38%182 412
More Results